Rheumatology and psychiatry: allies in times of COVID-19

Claudia Elera-Fitzcarrald; Jeff Huarcaya-Victoria; Graciela S. Alarcón; Manuel F. Ugarte-Gil

doi:10.1007/s10067-021-05792-7

Rheumatology and psychiatry: allies in times of COVID-19

Claudia Elera-Fitzcarrald, Jeff Huarcaya-Victoria, Graciela S. Alarcón, Manuel F. Ugarte-Gil

Research output: Contribution to journal › Review article › peer-review

6 Scopus citations

Abstract

The COVID-19 (coronavirus disease 2019) pandemic has had a significant global impact. Physical, emotional, and psychological health, particularly its specific mental health area, has been affected. Patients with rheumatic diseases are more likely to be concerned about COVID-19 than the public in general. Depression and anxiety are the symptoms most commonly reported by these patients. Therefore, now more than ever before, rheumatologists and psychiatrists should work together to improve the care of rheumatic disease patients, identifying the symptoms that uniquely reflect mental health problems, so the patients’ quality of life can be substantially improved.

Original language	English
Pages (from-to)	3363-3367
Number of pages	5
Journal	Clinical Rheumatology
Volume	40
Issue number	8
DOIs	https://doi.org/10.1007/s10067-021-05792-7
State	Published - Aug 2021

Bibliographical note

Publisher Copyright:
© 2021, International League of Associations for Rheumatology (ILAR).

Keywords

COVID-19
Coronavirus disease 2019
Mental health
Psychiatrists
Rheumatic diseases
Rheumatologists

Access to Document

10.1007/s10067-021-05792-7

Cite this

@article{6e75d1df1f0d4d82b6589e1198fac6ac,

title = "Rheumatology and psychiatry: allies in times of COVID-19",

abstract = "The COVID-19 (coronavirus disease 2019) pandemic has had a significant global impact. Physical, emotional, and psychological health, particularly its specific mental health area, has been affected. Patients with rheumatic diseases are more likely to be concerned about COVID-19 than the public in general. Depression and anxiety are the symptoms most commonly reported by these patients. Therefore, now more than ever before, rheumatologists and psychiatrists should work together to improve the care of rheumatic disease patients, identifying the symptoms that uniquely reflect mental health problems, so the patients{\textquoteright} quality of life can be substantially improved.",

keywords = "COVID-19, Coronavirus disease 2019, Mental health, Psychiatrists, Rheumatic diseases, Rheumatologists",

author = "Claudia Elera-Fitzcarrald and Jeff Huarcaya-Victoria and Alarc{\'o}n, {Graciela S.} and Ugarte-Gil, {Manuel F.}",

note = "Publisher Copyright: {\textcopyright} 2021, International League of Associations for Rheumatology (ILAR).",

year = "2021",

month = aug,

doi = "10.1007/s10067-021-05792-7",

language = "Ingl{\'e}s",

volume = "40",

pages = "3363--3367",

journal = "Clinical Rheumatology",

issn = "0770-3198",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "8",

}

TY - JOUR

T1 - Rheumatology and psychiatry

T2 - allies in times of COVID-19

AU - Elera-Fitzcarrald, Claudia

AU - Huarcaya-Victoria, Jeff

AU - Alarcón, Graciela S.

AU - Ugarte-Gil, Manuel F.

PY - 2021/8

Y1 - 2021/8

N2 - The COVID-19 (coronavirus disease 2019) pandemic has had a significant global impact. Physical, emotional, and psychological health, particularly its specific mental health area, has been affected. Patients with rheumatic diseases are more likely to be concerned about COVID-19 than the public in general. Depression and anxiety are the symptoms most commonly reported by these patients. Therefore, now more than ever before, rheumatologists and psychiatrists should work together to improve the care of rheumatic disease patients, identifying the symptoms that uniquely reflect mental health problems, so the patients’ quality of life can be substantially improved.

AB - The COVID-19 (coronavirus disease 2019) pandemic has had a significant global impact. Physical, emotional, and psychological health, particularly its specific mental health area, has been affected. Patients with rheumatic diseases are more likely to be concerned about COVID-19 than the public in general. Depression and anxiety are the symptoms most commonly reported by these patients. Therefore, now more than ever before, rheumatologists and psychiatrists should work together to improve the care of rheumatic disease patients, identifying the symptoms that uniquely reflect mental health problems, so the patients’ quality of life can be substantially improved.

KW - COVID-19

KW - Coronavirus disease 2019

KW - Mental health

KW - Psychiatrists

KW - Rheumatic diseases

KW - Rheumatologists

UR - http://www.scopus.com/inward/record.url?scp=85106724305&partnerID=8YFLogxK

U2 - 10.1007/s10067-021-05792-7

DO - 10.1007/s10067-021-05792-7

M3 - Artículo de revisión

AN - SCOPUS:85106724305

SN - 0770-3198

VL - 40

SP - 3363

EP - 3367

JO - Clinical Rheumatology

JF - Clinical Rheumatology

IS - 8

ER -

Rheumatology and psychiatry: allies in times of COVID-19

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this